Brian Crombie Radio Hour - Epi 1006 - Potential Breakthrough Drug in Individuals with Spinal Cord Injury with NervGen Pharma Team

Brian speaks with a team from NervGen Pharma. It is a Canadian start up trying to solve spinal cord injury. He is joined by:<br /><ul><li>Dr. Harold Punnett, Co-Founder</li><li>Mike Kelly, President &amp; CEO,</li><li>Dr Jerry Silver, Co-Inventor &amp; Scientific Advisor. </li></ul>NervGen Pharma’s highly anticipated Phase II study of the potentially breakthrough drug NVG-291 in individuals with Spinal Cord Injury (SCI) isn’t just “another clinical trial.” This drug has the potential to be transformational to the over 300,000 individuals who suddenly and without preparation or warning, suffered a life-altering traumatic injury resulting in either a significant disability or paralysis that has become “permanent” and with little to no hope for recovery or improvement.<br />